Eli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadership in anti-obesity drugs through ongoing innovation and development. With successful trials for drugs like retatrutide and Foundayo, Lilly is expanding its product offerings. The company recognizes the importance of India as a growing market for healthcare investments and partnerships.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/s7BoJzj
via IFTTT
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
-
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and...
-
The establishment inspection report (EIR) was issued after the last inspection of the facility conducted from October 17-29, 2022, the compa...
Search This Blog
Powered by Blogger.
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment